We are live on ! Find out more
CP

CenterBook Partners Portfolio holdings

AUM $1.86B
1-Year Est. Return 24.52%
This Fund
S&P 500
This Quarter Est. Return
+3.71%
1 Year Est. Return
+24.52%
3 Year Est. Return
+37.52%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.63B
AUM Growth
+$17.6M
Cap. Flow
-$28.1M
Cap. Flow %
-1.73%
Top 10 Hldgs %
16.75%
Holding
550
New
162
Increased
85
Reduced
194
Closed
109

Top Buys

Rank Stock Value
1
COST icon
Costco
COST
+$27.3M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$26.3M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$21.2M
4
MSFT icon
Microsoft
MSFT
+$21.1M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$20.5M

Top Sells

Rank Stock Value
1
ARGX icon
argenx
ARGX
+$9.91M
2
WEX icon
WEX
WEX
+$9.81M
3
FIVE icon
Five Below
FIVE
+$9.49M
4
GEV icon
GE Vernova
GEV
+$9.27M
5
LBRT icon
Liberty Energy
LBRT
+$9.24M

Sector Composition

Rank Sector Weight
1 Technology 27.72%
2 Healthcare 14.73%
3 Consumer Discretionary 10.43%
4 Communication Services 8.79%
5 Consumer Staples 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
USPH icon
76
US Physical Therapy
USPH
$1.22B
$6.59M 0.4%
77,813
+71,513
+1,135% +$6.35M
AMPS
77
DELISTED
Altus Power
AMPS
$6.57M 0.4%
2,066,732
+388,793
+23% +$1.39M
NAT icon
78
Nordic American Tanker
NAT
$1.36B
$6.48M 0.4%
1,766,106
+289,100
+20% +$1.06M
CL icon
79
Colgate-Palmolive
CL
$74.8B
$6.43M 0.4%
+61,945
New +$6.31M
ARHS icon
80
Arhaus
ARHS
$1.07B
$6.33M 0.39%
514,388
+258,565
+101% +$3.49M
RPRX icon
81
Royalty Pharma
RPRX
$26.2B
$6.17M 0.38%
+218,260
New +$6.05M
INSM icon
82
Insmed
INSM
$22.4B
$5.94M 0.37%
+81,336
New +$6M
BIIB icon
83
Biogen
BIIB
$30.9B
$5.81M 0.36%
29,987
-26,841
-47% -$5.62M
PCOR icon
84
Procore
PCOR
$7.57B
$5.7M 0.35%
+92,306
New +$5.66M
CARG icon
85
CarGurus
CARG
$3.34B
$5.46M 0.34%
181,776
-50,767
-22% -$1.37M
INDV icon
86
Indivior Pharmaceuticals
INDV
$4.74B
$5.45M 0.33%
+558,683
New +$6.54M
MRVL icon
87
Marvell Technology
MRVL
$147B
$5.44M 0.33%
75,455
-38,849
-34% -$2.68M
DX
88
Dynex Capital
DX
$3.18B
$5.44M 0.33%
426,402
+81,159
+24% +$1M
EXPE icon
89
Expedia Group
EXPE
$36.5B
$5.43M 0.33%
36,688
-54,128
-60% -$7.17M
FROG icon
90
JFrog
FROG
$8.88B
$5.43M 0.33%
186,825
+31,107
+20% +$977K
AGCO icon
91
AGCO
AGCO
$8.41B
$5.41M 0.33%
55,292
-10,594
-16% -$987K
DNB
92
DELISTED
Dun & Bradstreet
DNB
$5.33M 0.33%
463,309
-42,801
-8% -$475K
ESPR
93
DELISTED
Esperion Therapeutics
ESPR
$5.14M 0.32%
3,112,585
+1,543,126
+98% +$3.12M
LGND icon
94
Ligand Pharmaceuticals
LGND
$5.77B
$5.1M 0.31%
50,976
-2,403
-5% -$242K
CC icon
95
Chemours
CC
$2.48B
$5.06M 0.31%
+249,207
New +$5.09M
INDI icon
96
indie Semiconductor
INDI
$636M
$5.06M 0.31%
1,268,690
+693,921
+121% +$3.37M
TD icon
97
Toronto Dominion Bank
TD
$193B
$5.03M 0.31%
79,495
-103,937
-57% -$6.14M
ORCL icon
98
Oracle
ORCL
$339B
$5M 0.31%
+29,354
New +$4.25M
CGEM icon
99
Cullinan Oncology
CGEM
$1.06B
$5M 0.31%
298,666
-42,596
-12% -$756K
KD icon
100
Kyndryl
KD
$3.09B
$4.96M 0.3%
215,657
-41,451
-16% -$1.01M
2 3
4
5 6

Similar funds

WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
GRA
Goehring & Rozencwajg Associates New York $1.86B AUM 130.26% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
EAM
Evanson Asset Management Carmel, California $1.86B AUM 25.39% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return
CFA
Capstone Financial Advisors Downers Grove, Illinois $1.86B AUM 15.98% 1-Year Est. Return
OFG
Oxford Financial Group Carmel, Indiana $1.86B AUM 19.25% 1-Year Est. Return

CenterBook Partners's Q3 2024 Portfolio in Review

As of Q3 2024, CenterBook Partners held 550 positions worth $1.63B, up 1.1% from $1.61B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

CenterBook Partners's Q3 2024 filing shows 162 new, 85 increased, 194 reduced and 109 closed positions. Its largest new stake was Costco: 31,431 shares worth $27.9M. The largest sale was argenx, an estimated $9.91M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • CenterBook Partners's largest Q3 2024 buy was Costco: 31,431 shares worth $27.9M.
  • CenterBook Partners added most to Regeneron Pharmaceuticals in Q3 2024, an estimated $21.2M increase.
  • CenterBook Partners's biggest Q3 2024 reduction was argenx, cutting an estimated $9.91M.
  • CenterBook Partners fully exited Five Below in Q3 2024, selling an estimated $9.49M.
  • CenterBook Partners's ten largest holdings make up 17% of its $1.63B portfolio in Q3 2024.
  • CenterBook Partners opened 162 new positions and closed 109 in Q3 2024.
  • CenterBook Partners's portfolio value rose 1.1% quarter-over-quarter to $1.63B.

Based on CenterBook Partners's 13F filing for Q3 2024, filed 14 Nov 2024.